TD Cowen Maintains Buy on Johnson & Johnson, Lowers Price Target to $185
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Joshua Jennings maintains a Buy rating on Johnson & Johnson (NYSE:JNJ) but lowers the price target from $195 to $185.
July 18, 2024 | 3:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TD Cowen analyst Joshua Jennings maintains a Buy rating on Johnson & Johnson but lowers the price target from $195 to $185.
The Buy rating suggests continued confidence in JNJ's long-term prospects, but the lowered price target indicates some caution about short-term performance. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100